Please use this identifier to cite or link to this item: doi:10.22028/D291-46323
Title: Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3+☆,☆☆
Author(s): Hierlmeier, Ina
Randhawa, Parmissa
McNeil, Brooke L.
Oliveri, Elisa
Maus, Stephan
Radchenko, Valery
Rosar, Florian
Ezziddin, Samer
Bartholomä, Mark D.
Language: English
Title: Nuclear Medicine and Biology
Volume: 146-147
Publisher/Platform: Elsevier
Year of Publication: 2025
Free key words: Bifunctional chelator
Cyclen
Azaheterocycle
DOTI-me
DOTThia
Actinium-225
Bismuth-213
Lead-212
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: In this work, we introduce the cyclen-based metal chelator DOTThia comprising four methylthiazole arms for metal complexation. Together with the recently described congener DOTI-Me bearing four methylimidazole arms, the radiochemistry of these two compounds with 212Pb, 213Bi, and 225Ac was investigated thoroughly. Radiolabeling experiments were performed at various pH values and temperatures to determine the optimal conditions for quantitative radiochemical conversions. Experiments revealed excellent complexation properties of DOTThia for 212Pb at room temperature, comparable to those of the current gold standard for Pb complexation, TCMC, while it was not well suited for 213Bi. Contrarily, DOTI-Me exhibited quantitative radiochemical conversions for 213Bi at pH 5.5 and room temperature, outperforming the metal chelator macropa, but was not able to quantitatively complex 212Pb under any conditions investigated. Of note, both novel chelators were not able to bind 225Ac. In preliminary experiments, we could also show that a functionalized DOTI-Me derivative is capable of complexing 213Bi selectively from 225Ac solutions. This feature may allow the preparation of 213Bi-labeled radiotracers directly from 225Ac solutions without the need for an 225Ac/213Bi generator. However, more detailed studies are needed to fully explore this potential application. Altogether, our results support the future development of 212Pb-labeled radiopharmaceuticals using bifunctional derivatives of DOTThia as well as of 213Bi-labeled radiotracers based on the DOTI-Me scaffold.
DOI of the first publication: 10.1016/j.nucmedbio.2025.109034
URL of the first publication: https://doi.org/10.1016/j.nucmedbio.2025.109034
Link to this record: urn:nbn:de:bsz:291--ds-463230
hdl:20.500.11880/40598
http://dx.doi.org/10.22028/D291-46323
ISSN: 0969-8051
Date of registration: 24-Sep-2025
Description of the related object: Supplementary data
Related object: https://ars.els-cdn.com/content/image/1-s2.0-S0969805125000435-mmc1.pdf
Faculty: M - Medizinische Fakultät
Department: M - Radiologie
Professorship: M - Prof. Dr. Samer Ezziddin
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
1-s2.0-S0969805125000435-main.pdf3,11 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons